In observance of the 20th HIV Vaccine Awareness Day (May 18), Dr. Hanneke Schuitemaker, Head of Viral Vaccine Discovery and Translational Medicine at Janssen Vaccines, and Matthew Hodson, Executive Director of the HIV/AIDS information provider NAM, sat down with The Business Debate. During the interview, they discussed the challenges involved in developing an HIV vaccine and the importance of global partnerships if we are to achieve an HIV-free world. For more information about Johnson & Johnson’s work to fight HIV/AIDS, go to www.jnj.com/hiv.
